Form 4 Tracker
Royalty Pharma plc
RPRX

46 insider filings · Latest: Oct 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 5, 2026Oct 5 9:12 PMMarshall UristEVP, Research & Investments
Sale
4,126$57.10$235.6K0(D)

View →

Oct 5, 2026Oct 5 8:02 PMUrist Marshall
Proposed Sale
4,126$57.10$235.6K—

View →

Sep 28, 2026Sep 30 8:32 PMMarshall UristEVP, Research & Investments
Sale
4,126$57.88$238.8K4,126(D)

View →

Sep 28, 2026Sep 28 8:09 PMUrist Marshall
Proposed Sale
4,126$57.88$238.8K—

View →

Sep 22, 2026Sep 24 8:10 PMChristopher HiteEVP & Chairman, Partnering
Sale
100,000$58.53$5.9M270,401(I)

View →

Sep 22, 2026Sep 22 8:50 PMSCH Investment Partners LLC
Proposed Sale
100,000$58.47$5.8M—

View →

Aug 18, 2026Aug 19 8:20 PMChristopher HiteEVP & Chairman, Partnering
Sale
100,000$59.97$6.0M370,401(I)

View →

Aug 18, 2026Aug 18 8:45 PMSCH Investment Partners LLC
Proposed Sale
100,000$60.12$6.0M—

View →

Aug 13, 2026Aug 17 9:01 PMTerrance P. CoyneEVP & CFO
Sale
11,002$58.68$645.6K0(I)

View →

Aug 13, 2026Aug 13 8:43 PMTerrance Coyne
Proposed Sale
11,002$58.56$644.3K—

View →

Aug 12, 2026Aug 12 10:32 PMErrol B. De Souza
Proposed Sale
206,352$57.79$11.9M—

View →

Aug 12, 2026Aug 12 10:28 PMErrol B. De Souza
Proposed Sale
125,000$57.79$7.2M—

View →

Jul 1, 2026Jul 2 8:10 PMMarshall UristEVP, Research & Investments
Sale
9,099$55.88$508.5K0(D)

View →

Jun 30, 2026Jul 2 8:08 PMChristopher HiteEVP & Chairman, Partnering
Sale
130,000$56.50$7.3M40,000(I)

View →

Jul 1, 2026Jul 1 8:18 PMUrist Marshall
Proposed Sale
9,099$55.88$508.5K—

View →

Jun 30, 2026Jul 1 12:24 PMSCH Investment Partners LLC
Proposed Sale
100,000$57.09$5.7M—

View →

Jun 24, 2026Jun 25 9:13 PMMarshall UristEVP, Research & Investments
Sale
9,098$55.18$502.1K9,099(D)

View →

Jun 23, 2026Jun 25 9:11 PMChristopher HiteEVP & Chairman, Partnering
Sale
150,000$54.40$8.2M559,399(I)

View →

Jun 24, 2026Jun 24 8:14 PMUrist Marshall
Proposed Sale
9,098$55.18$502.1K—

View →

Jun 23, 2026Jun 23 8:48 PMChristopher Hite
Proposed Sale
30,000$55.35$1.7M—

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 7, 2026Aug 7 9:24 PMPablo G. LegorretaDirector, CEO, Chairman of the Board
Gift
30,000—662,701(D)

View →

Aug 7, 2026Aug 7 9:24 PMTerrance P. CoyneEVP & CFO
Gift
18,500—1,788,777(I)

View →

Aug 7, 2026Aug 7 9:11 PMMarshall UristEVP, Research & Investments
Gift
3,000—244,412(I)

View →